Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 23 | 19 | 0 | 0 | 160 |
| Cost of Goods | 12 | 7 | 0 | 0 | 0 |
| Gross Profit | 11 | 11 | 0 | 0 | 160 |
| Operating Expenses | 439 | 329 | 489 | 289 | 280 |
| Operating Income | -428 | -317 | -489 | -289 | -120 |
| Interest Expense | 27 | 26 | 25 | 24 | 3 |
| Other Income | -1 | 1 | 3 | 7 | -3 |
| Pre-tax Income | -455 | -342 | -511 | -306 | -126 |
| Net Income Continuous | -455 | -342 | -511 | -306 | -126 |
| Net Income | $-455 | $-342 | $-511 | $-306 | $-126 |
| EPS Basic Total Ops | -0.04 | 0.00 | -0.04 | 0.00 | 0.00 |
| EPS Basic Continuous Ops | -0.04 | 0.00 | -0.04 | 0.00 | 0.00 |
| EPS Diluted Total Ops | -0.04 | 0.00 | -0.04 | 0.00 | 0.00 |
| EPS Diluted Continuous Ops | -0.04 | 0.00 | -0.04 | 0.00 | 0.00 |
| EBITDA(a) | $-418 | $-307 | $-477 | $-273 | $-114 |